Much more often than not, attempting to talk to friends or family members about their potential drug or alcohol abuse is a sensitive, challenging, and sometimes painful undertaking. It is natural for an individual who is addicted to drugs or alcohol, not to recognize the long-term consequences that cause pain and suffering to more people than just themselves. When seeking to help others overcome their addiction and the constant struggle with substance abuse, sometimes it is through those caring friends or family members that the user can finally find some relief2 by setting boundaries.
A look at some of the more interesting scientific studies recently published, including the COVID-19 lockdown causing increased mental health issues.
Powered by Xconomy, November 2019’s What’s Next in Neuroscience Therapies event brought together scientists, entrepreneurs and biotech executives at the Hyatt Regency San Francisco to discuss their work developing next-generation neuroscience therapies and technologies in areas such as spinal-cord injuries, precision mental health, dementia and Alzheimer’s disease.
Researchers said Evidence is weak for whether medicinal cannabis treatments can relieve mental illnesses such as anxiety, depression and psychosis, and doctors should prescribe them with great caution.
Healthline Media and the National Alliance on Mental Illness announced the winners of the Healthline Stronger Scholarship, which is awarded to four university students around the U.S. for their commitment to academic and professional pursuits in mental health.
Poor sleep may be linked to a greater risk for poor mental health on college campuses, new research suggests.
Allergan Plc’s Vraylar won U.S. regulatory approval to treat depressive episodes of bipolar I disorder, expanding the scope of treatment to a full spectrum of symptoms related to the condition.
Sage Therapeutics shares were up after the company won approval for the postpartum depression treatment Zulresso (brexanalone).
Socially isolated people may be more likely to develop diabetes than adults with closer ties to family and friends, a recent study suggests.
Science needs champions. That is the belief of Johnson & Johnson’s Seema Kumar, vice president of Innovation, Global Health and Science Policy Communication. And that is a belief being harnessed by a new J&J initiative that celebrates the legacy of Dr. Paul Janssen, one of the most prolific scientific innovators of the past century.